Clinical trials are an important part of finding new treatments for cancer. At the Stanford Cancer Institute, we are committed to diversity and inclusion in clinical trial participation in order to develop targeted treatments that are effective for all populations. #cancer #clinicaltrials #medicalscience

Learn more about our Cancer Clinical Trials: med.stanford.edu/cancer/trials.html
Learn more about the Stanford Cancer Institute: med.stanford.edu/cancer

Follow the Stanford Cancer Institute
LinkedIn: linkedin.com/company/stanford-cancer/
Twitter: Twitter: twitter.com/scidirector
Subscribe to the Stanford Cancer Institute: youtube.com/@stanfordcancerinstitute/

• Diversity and Inclusion in Clinical Trials | Stanford Cancer Institute ( Download)
• Advancing Diversity in Clinical Trials ( Download)
• Why Is Diversity in Clinical Trials Important ( Download)
• The Importance of Diversity in Clinical Trials ( Download)
• Diversity in Clinical Trials ( Download)
• Why Diversity Matters in Clinical Trials ( Download)
• Diversity in Clinical Trials ( Download)
• How diversity and inclusion impact clinical trial delivery | Twinkle Bahaduri | TEDxKew ( Download)
• Application of Artificial Intelligence to the ECG | Peter Noseworthy, MD, MBA ( Download)
• Disrupting the Status Quo: The Importance of Diversity in Clinical Trials ( Download)
• Diversity in Clinical Trials ( Download)
• Diversity in Clinical Trials ( Download)
• The Four Phases of Clinical Trials | Diversity in Clinical Trials | AKF ( Download)
• Diversity in clinical trials: Why including every eligible patient matters ( Download)
• FDA says diversity now required in clinical trials ( Download)